Inhibition of thrombin generation by protein S at low procoagulant stimuli:: implications for maintenance of the hemostatic balance

被引:59
作者
Seré, KM [1 ]
Rosing, J [1 ]
Hackeng, TM [1 ]
机构
[1] Univ Maastricht, Dept Biochem, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands
关键词
D O I
10.1182/blood-2004-03-1146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The activated protein C (APC)-independent anticoagulant activity of protein S on tissue factor-induced thrombin generation was quantified in plasma. In absence of APC, protein S significantly decreased the endogenous thrombin potential (ETP) in a concentration-dependent manner. The APC-independent anticoagulant activity of protein S in plasma was not affected by phospholipid concentrations but strongly depended on tissue factor concentrations: protein S inhibited the ETP from 6% at 140 pM tissue factor to 74% at 1.4 pM tissue factor. Plasma with both 60% protein S and 140% prothrombin showed an ETP of 240% compared to normal plasma, suggesting an APC-independent protective role of protein S in the development of thrombosis as a result of protein S deficiency and the prothrombin-G20210A mutation. At high tissue-factor concentrations, protein S hardly expressed APC-independent anticoagulant activity but exerted potent APC-cofactor activity when thrombomodulin or APC were added to plasma. Neutralization of protein S under these conditions resulted in a 20-fold reduction of the anticoagulant activity of APC. The present study shows that protein S effectively regulates coagulation at 2 levels: at low procoagulant stimuli, protein S maintains the hemostatic balance by directly inhibiting thrombin formation, and at high procoagulant stimuli, protein S restores the hemostatic balance via its APC-cofactor activity. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:3624 / 3630
页数:7
相关论文
共 31 条
[11]   C-terminal residues 621-635 of protein S are essential for binding to factor Va [J].
Heeb, MJ ;
Kojima, Y ;
Rosing, J ;
Tans, G ;
Griffin, JH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (51) :36187-36192
[12]   PROTEIN-S BINDS TO AND INHIBITS FACTOR-XA [J].
HEEB, MJ ;
ROSING, J ;
BAKKER, HM ;
FERNANDEZ, JA ;
TANS, G ;
GRIFFIN, JH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) :2728-2732
[13]  
HEEB MJ, 1993, J BIOL CHEM, V268, P2872
[14]   Calibrated automated thrombin generation measurement in clotting plasma [J].
Hemker, HC ;
Giesen, P ;
Al Dieri, R ;
Regnault, V ;
de Smedt, E ;
Wagenvoord, R ;
Lecompte, T ;
Béguin, S .
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2003, 33 (01) :4-15
[15]  
KALAFATIS M, 1994, J BIOL CHEM, V269, P31869
[16]   INACTIVATION OF HUMAN FACTOR-VIII BY ACTIVATED PROTEIN-C - COFACTOR ACTIVITY OF PROTEIN-S AND PROTECTIVE EFFECT OF VONWILLEBRAND-FACTOR [J].
KOEDAM, JA ;
MEIJERS, JCM ;
SIXMA, JJ ;
BOUMA, BN .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (04) :1236-1243
[17]   The APC-independent anticoagulant activity of protein S in plasma is decreased by elevated prothrombin levels due to the prothrombin G20210A mutation [J].
Koenen, RR ;
Tans, G ;
van Oerle, R ;
Hamulyák, K ;
Rosing, J ;
Hackeng, TM .
BLOOD, 2003, 102 (05) :1686-1692
[18]  
NELSESTUEN GL, 1976, J BIOL CHEM, V251, P5648
[19]  
NELSESTUEN GL, 1976, J BIOL CHEM, V251, P6886
[20]   Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex [J].
Rezende, SM ;
Simmonds, RE ;
Lane, DA .
BLOOD, 2004, 103 (04) :1192-1201